David D'Andrea
David D'Andrea
Verified email at - Homepage
Cited by
Cited by
Characteristics and clinical significance of histological variants of bladder cancer
M Moschini, D D'andrea, S Korn, Y Irmak, F Soria, E Compérat, SF Shariat
Nature Reviews Urology 14 (11), 651-668, 2017
PSMA ligand PET/MRI for primary prostate cancer: staging performance and clinical impact
B Grubmüller, P Baltzer, S Hartenbach, D D’Andrea, TH Helbich, ...
Clinical Cancer Research 24 (24), 6300-6307, 2018
Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007–2018 data
M Abufaraj, T Xu, C Cao, T Waldhoer, C Seitz, D D’andrea, A Siyam, ...
European urology focus 7 (6), 1468-1475, 2021
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
B Grubmüller, D Senn, G Kramer, P Baltzer, D D’Andrea, KH Grubmüller, ...
European journal of nuclear medicine and molecular imaging 46, 1063-1072, 2019
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
F Soria, MJ Droller, Y Lotan, P Gontero, D D’Andrea, KM Gust, M Rouprêt, ...
World journal of urology 36, 1981-1995, 2018
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic …
B Grubmüller, P Baltzer, D D’andrea, S Korn, AR Haug, M Hacker, ...
European journal of nuclear medicine and molecular imaging 45, 235-242, 2018
External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis
M Moschini, E Zaffuto, PI Karakiewicz, DD Andrea, B Foerster, M Abufaraj, ...
European urology 75 (2), 319-328, 2019
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
F Soria, AI Beleni, D D’Andrea, I Resch, KM Gust, P Gontero, SF Shariat
World Journal of Urology 36, 1703-1709, 2018
Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic …
B Foerster, C Pozo, M Abufaraj, A Mari, S Kimura, D D’Andrea, H John, ...
JAMA oncology 4 (7), 953-961, 2018
Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature
B Foerster, D D'Andrea, M Abufaraj, S Broenimann, PI Karakiewicz, ...
Urologic Oncology: Seminars and Original Investigations 37 (7), 430-436, 2019
Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis
P Rajwa, B Pradere, F Quhal, K Mori, E Laukhtina, NA Huebner, ...
European urology 80 (5), 549-563, 2021
Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
D D'Andrea, F Soria, S Zehetmayer, KM Gust, S Korn, JA Witjes, ...
BJU international 123 (6), 959-967, 2019
A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
A Mari, S Kimura, B Foerster, M Abufaraj, D d'Andrea, M Hassler, ...
BJU international 123 (1), 11-21, 2019
Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and …
S Zamboni, F Soria, R Mathieu, E Xylinas, M Abufaraj, D DAndrea, ...
BJU international 124 (4), 656-664, 2019
Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer
B Grubmüller, S Rasul, P Baltzer, H Fajkovic, D D'Andrea, F Berndl, ...
The Prostate 80 (1), 74-82, 2020
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic …
S Berg, D D’Andrea, MW Vetterlein, AP Cole, SA Fletcher, MJ Krimphove, ...
Cancer 125 (9), 1449-1458, 2019
Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour
R Suarez‐Ibarrola, F Soria, M Abufaraj, D D'Andrea, M Preto, KM Gust, ...
BJU international 123 (4), 646-650, 2019
A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer
A Mari, S Kimura, B Foerster, M Abufaraj, D D'Andrea, KM Gust, ...
Urologic oncology: seminars and original investigations 36 (6), 293-305, 2018
En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature
K Mori, D D’Andrea, DV Enikeev, S Egawa, SF Shariat
Current Opinion in Urology 30 (1), 41-47, 2020
Lymphocyte‐to‐monocyte ratio and neutrophil‐to‐lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy
D D'Andrea, M Moschini, KM Gust, M Abufaraj, M Özsoy, R Mathieu, ...
Journal of surgical oncology 115 (4), 455-461, 2017
The system can't perform the operation now. Try again later.
Articles 1–20